Quality of Life for Men Receiving a Second Treatment for Prostate Cancer

Journal of Urology

Volumn 177, Issue 1, 2007, Pages 273-279

  Arredondo, Shelley A ^a   Latini, David M ^b   Sadetsky, Natalia ^a   Kawakami, Jun ^c   Pasta, David J ^a   DuChane, Janeen ^d   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d TAP PHARMACEUTICAL PRODUCTS INC   (United States)

Author keywords

outcome assessment; prostatic neoplasms; quality of life

Indexed keywords

HORMONE; PROSTATE STEM CELL ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEXUALITY; SHORT FORM 36; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

AGED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RETREATMENT;

EID: 33845442927     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.061     Document Type: Article

References (20)

1. Stock R.G. Locoregional therapies for early-stage prostate cancer. Oncology (Huntingt) 9 (1995) 803
2. Cooperberg M.R., Broering J.M., Latini D.M., Litwin M.S., Wallace K.L., and Carroll P.R. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep 5 (2004) 166
3. Moul J.W. Treatment options for prostate cancer: part 1-stage, grade, PSA, and changes in the 1990's. Am J Manag Care 4 (1998) 1031
4. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591
5. Potosky A.L., Davis W.W., Hoffman R.M., Stanford J.L., Stephenson R.A., Penson D.F., et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96 (2004) 1358
6. Lubeck D.P., Litwin M.S., Henning J.M., Stoddard M.L., Flanders S.C., and Carroll P.R. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 53 (1999) 180
7. Hu J.C., Elkin E.P., Pasta D.J., Lubeck D.P., Kattan M.W., Carroll P.R., et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 171 (2004) 703
8. Penson D.F., McLerran D., Feng Z., Li L., Albertsen P.C., Gilliland F.D., et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 173 (2005) 1701
9. Litwin M.S. Quality of life following definitive therapy for localized prostate cancer: potential impact of multiple therapies. Curr Opin Urol 13 (2003) 153
10. Tefilli M.V., Gheiler E.L., Tiguert R., Barroso Jr. U., Barton C.D., Wood Jr. D.P., et al. Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer. J Surg Oncol 69 (1998) 156
11. Pietrow P.K., Parekh D.J., Smith Jr. J.A., Shyr Y., and Cookson M.S. Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. J Urol 166 (2001) 2286
12. Lubeck D.P., Litwin M.S., Henning J.M., Stier D.M., Mazonson P., Fisk R., et al., CaPSURE Research Panel. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48 (1996) 773
13. Ware J.E., Snow K.K., and Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide (2000), QualityMetric, Inc, Lincoln, Rhode Island
14. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., and Brook R.H. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002
15. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989) 407
16. Ware J., Kosinski M., and Keller S. SF-36 Physical and Mental Health Summary Scales: A User's Manual (1994), New England Medical Center, Boston
17. Fowler Jr. F.J., McNaughton Collins M., Walker Corkery E., Elliott D.B., and Barry M.J. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer 95 (2002) 287
18. Grossfeld G.D., Small E.J., Lubeck D.P., Latini D., Broering J.M., and Carroll P.R. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy. Urology 58 (2001) 56
19. Pearce A., Choo R., Danjoux C., Morton G., Loblaw D.A., Szumacher E., et al. Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys 65 (2006) 78
20. Hu J.C., Elkin E.P., and Litwin M.S. The effect of post-prostatectomy external beam radiotherapy on quality of life: results from CaPSURE. J Urol 173 (2005) 56